EdgarLookup

RENASANT CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that RENASANT CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
0.7%
Return on Assets
Net income ÷ assets
5.89x
Debt-to-Equity
Total liabilities ÷ equity

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $181.27M Mar 2, 2026
FY2025 Dec 31, 2024 $195.46M Mar 2, 2026
FY2025 Dec 31, 2023 $144.68M Mar 2, 2026
FY2024 Dec 31, 2022 $166.07M Feb 26, 2025
FY2023 Dec 31, 2021 $175.89M Feb 23, 2024
FY2020 Dec 31, 2020 $31.52M Feb 26, 2021
FY2020 Sep 30, 2020 $29.99M Feb 26, 2021
FY2020 Jun 30, 2020 $20.13M Feb 26, 2021
FY2020 Mar 31, 2020 $2.01M Feb 26, 2021
FY2020 Dec 31, 2019 $38.42M Feb 26, 2021

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $271.47M Mar 2, 2026
FY2025 Dec 31, 2024 $106.42M Mar 2, 2026
FY2025 Dec 31, 2023 $148.55M Mar 2, 2026
FY2024 Dec 31, 2022 $574.05M Feb 26, 2025
FY2023 Dec 31, 2021 $142.66M Feb 23, 2024
FY2022 Dec 31, 2020 $82.24M Feb 24, 2023
FY2021 Dec 31, 2019 $163.62M Feb 25, 2022
FY2020 Dec 31, 2018 $82.11M Feb 26, 2021
FY2019 Dec 31, 2017 $207.04M Feb 27, 2020
FY2018 Dec 31, 2016 $163.80M Feb 27, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $33.72M Mar 2, 2026
FY2025 Dec 31, 2024 $13.65M Mar 2, 2026
FY2025 Dec 31, 2023 $21.63M Mar 2, 2026
FY2024 Dec 31, 2022 $14.84M Feb 26, 2025
FY2023 Dec 31, 2021 $20.52M Feb 23, 2024
FY2022 Dec 31, 2020 $28.27M Feb 24, 2023
FY2021 Dec 31, 2019 $34.97M Feb 25, 2022
FY2020 Dec 31, 2018 $22.36M Feb 26, 2021
FY2019 Dec 31, 2017 $13.05M Feb 27, 2020
FY2018 Dec 31, 2016 $13.56M Feb 27, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $26.75B Mar 2, 2026
FY2025 Dec 31, 2024 $18.03B Mar 2, 2026
FY2025 Dec 31, 2023 $17.36B Mar 2, 2026
FY2024 Dec 31, 2022 $16.99B Feb 26, 2025
FY2023 Dec 31, 2021 $16.81B Feb 23, 2024
FY2022 Dec 31, 2020 $14.93B Feb 24, 2023
FY2021 Dec 31, 2019 $13.40B Feb 25, 2022
FY2020 Dec 31, 2018 $12.93B Feb 26, 2021
FY2019 Dec 31, 2017 $9.83B Feb 27, 2020
FY2018 Dec 31, 2016 $8.70B Feb 27, 2019

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $22.87B Mar 2, 2026
FY2025 Dec 31, 2024 $15.36B Mar 2, 2026
FY2024 Dec 31, 2023 $15.06B Feb 26, 2025
FY2023 Dec 31, 2022 $14.85B Feb 23, 2024
FY2022 Dec 31, 2021 $14.60B Feb 24, 2023
FY2021 Dec 31, 2020 $12.80B Feb 25, 2022
FY2020 Dec 31, 2019 $11.27B Feb 26, 2021
FY2019 Dec 31, 2018 $10.89B Feb 27, 2020
FY2018 Dec 31, 2017 $8.31B Feb 27, 2019
FY2017 Dec 31, 2016 $7.47B Feb 28, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.88B Mar 2, 2026
FY2025 Dec 31, 2024 $2.68B Mar 2, 2026
FY2025 Dec 31, 2023 $2.30B Mar 2, 2026
FY2025 Dec 31, 2022 $2.14B Mar 2, 2026
FY2024 Dec 31, 2021 $2.21B Feb 26, 2025
FY2023 Dec 31, 2020 $2.13B Feb 23, 2024
FY2022 Dec 31, 2019 $2.13B Feb 24, 2023
FY2021 Dec 31, 2018 $2.04B Feb 25, 2022
FY2020 Dec 31, 2017 $1.51B Feb 26, 2021
FY2019 Dec 31, 2016 $1.23B Feb 27, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.41B Mar 2, 2026
FY2025 Dec 31, 2024 $988.90M Mar 2, 2026
FY2025 Dec 31, 2023 $991.67M Mar 2, 2026
FY2024 Dec 31, 2022 $991.71M Feb 26, 2025
FY2023 Dec 31, 2021 $939.68M Feb 23, 2024
FY2022 Dec 31, 2020 $939.68M Feb 24, 2023
FY2021 Dec 31, 2019 $939.68M Feb 25, 2022
FY2020 Dec 31, 2018 $932.93M Feb 26, 2021
FY2019 Dec 31, 2017 $611.05M Feb 27, 2020
FY2018 Dec 31, 2016 $470.53M Feb 27, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.20B Mar 2, 2026
FY2025 Dec 31, 2024 $1.09B Mar 2, 2026
FY2024 Dec 31, 2023 $952.12M Feb 26, 2025
FY2023 Dec 31, 2022 $857.73M Feb 23, 2024
FY2022 Dec 31, 2021 $741.65M Feb 24, 2023
FY2021 Dec 31, 2020 $615.77M Feb 25, 2022
FY2020 Dec 31, 2019 $617.36M Feb 26, 2021
FY2019 Dec 31, 2018 $500.66M Feb 27, 2020
FY2018 Dec 31, 2017 $397.35M Feb 27, 2019
FY2017 Dec 31, 2016 $337.54M Feb 28, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.07B Mar 2, 2026
FY2025 Dec 31, 2024 $1.09B Mar 2, 2026
FY2024 Dec 31, 2023 $801.35M Feb 26, 2025
FY2023 Dec 31, 2022 $575.99M Feb 23, 2024
FY2022 Dec 31, 2021 $1.88B Feb 24, 2023
FY2021 Dec 31, 2020 $633.20M Feb 25, 2022
FY2020 Dec 31, 2019 $414.93M Feb 26, 2021
FY2019 Dec 31, 2018 $569.11M Feb 27, 2020
FY2018 Dec 31, 2017 $281.45M Feb 27, 2019
FY2018 Dec 31, 2016 $306.22M Feb 27, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $499.76M Mar 2, 2026
FY2025 Dec 31, 2024 $430.61M Mar 2, 2026
FY2024 Dec 31, 2023 $429.40M Feb 26, 2025
FY2023 Dec 31, 2022 $428.13M Feb 23, 2024
FY2022 Dec 31, 2021 $471.21M Feb 24, 2023
FY2021 Dec 31, 2020 $474.97M Feb 25, 2022
FY2020 Dec 31, 2019 $376.51M Feb 26, 2021
FY2019 Dec 31, 2018 $263.62M Feb 27, 2020
FY2018 Dec 31, 2017 $207.55M Feb 27, 2019
FY2017 Dec 31, 2016 $202.46M Feb 28, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 2 Mar 2, 2026
FY2025 Dec 31, 2024 3 Mar 2, 2026
FY2025 Dec 31, 2023 2 Mar 2, 2026
FY2024 Dec 31, 2022 2 Feb 26, 2025
FY2023 Dec 31, 2021 3 Feb 23, 2024
FY2020 Dec 31, 2020 0 Feb 26, 2021
FY2020 Sep 30, 2020 0 Feb 26, 2021
FY2020 Jun 30, 2020 0 Feb 26, 2021
FY2020 Mar 31, 2020 0 Feb 26, 2021
FY2020 Dec 31, 2019 0 Feb 26, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 2 Mar 2, 2026
FY2025 Dec 31, 2024 3 Mar 2, 2026
FY2025 Dec 31, 2023 2 Mar 2, 2026
FY2024 Dec 31, 2022 2 Feb 26, 2025
FY2023 Dec 31, 2021 3 Feb 23, 2024
FY2020 Dec 31, 2020 0 Feb 26, 2021
FY2020 Sep 30, 2020 0 Feb 26, 2021
FY2020 Jun 30, 2020 0 Feb 26, 2021
FY2020 Mar 31, 2020 0 Feb 26, 2021
FY2020 Dec 31, 2019 0 Feb 26, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 94.64M Mar 2, 2026
FY2025 Dec 31, 2024 63.57M Mar 2, 2026
FY2024 Dec 31, 2023 56.14M Feb 26, 2025
FY2023 Dec 31, 2022 55.95M Feb 23, 2024
FY2022 Dec 31, 2021 55.76M Feb 24, 2023
FY2021 Dec 31, 2020 56.20M Feb 25, 2022
FY2020 Dec 31, 2019 56.86M Feb 26, 2021
FY2019 Dec 31, 2018 58.55M Feb 27, 2020
FY2018 Dec 31, 2017 49.32M Feb 27, 2019
FY2017 Dec 31, 2016 44.32M Feb 28, 2018